Carregant...
A validated UHPLC-MS/MS method for rapid determination of senicapoc in plasma samples
The clinically tested KCa3.1 channel blocker, senicapoc, has been proven to have excellent pharmacological properties and prior clinical trials found it to be safe for use in patients with sickle cell anaemia. Currently, several preclinical projects are aiming to repurpose senicapoc for other indica...
Guardat en:
| Publicat a: | J Pharm Biomed Anal |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier B.V.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869607/ https://ncbi.nlm.nih.gov/pubmed/33626443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2021.113956 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|